| article_id i : | 466 |
| pubmed_id i : | 9619147 |
| doi i : | 10.1176/ajp.155.6.761 |
| pdf_filename i : | Abi-Dargham_et_al_1998 |
| title i : | Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort |
| citation i : | (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. The American journal of psychiatry. 10.1176/ajp.155.6.761 |
| include i : | 1 |
| independent i : | 1 |
| comments i : | No comments |
| status i : | 1 |
| creation_time i : | 2022-08-04 08:20:02 |
| modification_time i : | 2024-05-31 10:36:03 |
| created_by i : | joupes |
| modified_by i : | lihsun |
| contrast_id i : | 877 |
| contrast_name i : | Striatal Dopamine Transmission studied with 15 untreated patients with schizophrenia compared to 15 matched healthy subjects |
| article_id i : | 466 |
| modality i : | SPECT |
| target_molecule i : | D2D3 |
| tracer i : | [123I]IBZM |
| model i : | Reference model (occipital) |
| include i : | 1 |
| independent i : | 1 |
| comments i : | This replication study has the same healthy control subjects as in Laruelle et al 1996 |
| age_g1 i : | 40 |
| age_g1_males i : | -1 |
| age_g1_females i : | -1 |
| n_g1 i : | 15 |
| n_g1_males i : | 12 |
| n_g1_females i : | 3 |
| disorder_g1 i : | Healthy Controls |
| comorbidity_g1 i : | |
| premedication_g1 i : | |
| medicated_g1 i : | 0 |
| days_wo_drugs_g1 i : | |
| smoking_g1 i : | -1 |
| age_g2 i : | 42 |
| age_g2_males i : | -1 |
| age_g2_females i : | -1 |
| n_g2 i : | 15 |
| n_g2_males i : | 12 |
| n_g2_females i : | 3 |
| disorder_g2 i : | Schizophrenia |
| comorbidity_g2 i : | |
| premedication_g2 i : | Lorazepam (5), antipsychotics, amphetamine |
| medicated_g2 i : | 1 |
| days_wo_drugs_g2 i : | 1 |
| smoking_g2 i : | -1 |
| status i : | 1 |
| creation_time i : | 2022-08-04 08:20:24 |
| modification_time i : | 2024-05-31 10:35:45 |
| created_by i : | joupes |
| modified_by i : | lihsun |